|Nonpharmacological interventions for ADHD: systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments|
EJS Sonuga-Barke, D Brandeis, S Cortese, D Daley, M Ferrin, ...
American journal of psychiatry 170 (3), 275-289, 2013
|European clinical guidelines for hyperkinetic disorder–first upgrade|
E Taylor, M Döpfner, J Sergeant, P Asherson, T Banaschewski, ...
European child & adolescent psychiatry 13, i7-i30, 2004
|Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta …|
S Cortese, N Adamo, C Del Giovane, C Mohr-Jensen, AJ Hayes, ...
The Lancet Psychiatry 5 (9), 727-738, 2018
|The quality of life of children with attention deficit/hyperactivity disorder: a systematic review|
M Danckaerts, EJS Sonuga-Barke, T Banaschewski, J Buitelaar, ...
European child & adolescent psychiatry 19, 83-105, 2010
|Cognitive training for attention-deficit/hyperactivity disorder: meta-analysis of clinical and neuropsychological outcomes from randomized controlled trials|
S Cortese, M Ferrin, D Brandeis, J Buitelaar, D Daley, RW Dittmann, ...
Journal of the American Academy of Child & Adolescent Psychiatry 54 (3), 164-174, 2015
|Long-acting medications for the hyperkinetic disorders: a systematic review and European treatment guideline|
T Banaschewski, D Coghill, P Santosh, A Zuddas, P Asherson, J Buitelaar, ...
European child & adolescent psychiatry 15, 476-495, 2006
|European guidelines on managing adverse effects of medication for ADHD|
J Graham, T Banaschewski, J Buitelaar, D Coghill, M Danckaerts, ...
European child & adolescent psychiatry 20, 17-37, 2011
|Neurofeedback for attention-deficit/hyperactivity disorder: meta-analysis of clinical and neuropsychological outcomes from randomized controlled trials|
S Cortese, M Ferrin, D Brandeis, M Holtmann, P Aggensteiner, D Daley, ...
Journal of the American Academy of Child & Adolescent Psychiatry 55 (6), 444-455, 2016
|Antipsychotics in children and adolescents: increasing use, evidence for efficacy and safety concerns|
B Vitiello, C Correll, B van Zwieten-Boot, A Zuddas, M Parellada, ...
European Neuropsychopharmacology 19 (9), 629-635, 2009
|Psychosocial risk factors for suicidality in children and adolescents|
JJ Carballo, C Llorente, L Kehrmann, I Flamarique, A Zuddas, ...
European child & adolescent psychiatry 29, 759-776, 2020
|Contrasting deficits on executive functions between ADHD and reading disabled children|
GM Marzocchi, J Oosterlaan, A Zuddas, P Cavolina, H Geurts, D Redigolo, ...
Journal of Child Psychology and Psychiatry 49 (5), 543-552, 2008
|ADHD management during the COVID-19 pandemic: guidance from the European ADHD Guidelines Group|
S Cortese, P Asherson, E Sonuga-Barke, T Banaschewski, D Brandeis, ...
The Lancet Child & Adolescent Health 4 (6), 412-414, 2020
|Prevalence and correlates of mental disorders among adolescents in Italy: the PrISMA study|
A Frigerio, P Rucci, R Goodman, M Ammaniti, O Carlet, P Cavolina, ...
European child & adolescent psychiatry 18, 217-226, 2009
|Cardiovascular effects of stimulant and non-stimulant medication for children and adolescents with ADHD: a systematic review and meta-analysis of trials of methylphenidate …|
L Hennissen, MJ Bakker, T Banaschewski, S Carucci, D Coghill, ...
CNS drugs 31, 199-215, 2017
|Relapse prevention in pediatric patients with ADHD treated with atomoxetine: a randomized, double-blind, placebo-controlled study|
D Michelson, JK Buitelaar, M Danckaerts, C Gillberg, TJ Spencer, ...
Journal of the American Academy of Child & Adolescent Psychiatry 43 (7), 896-904, 2004
|MK‐801 prevents 1‐methyl‐4‐phenyl‐1, 2, 3, 6‐tetrahydropyridine‐induced parkinsonism in primates|
A Zuddas, G Oberto, F Vaglini, F Fascetti, F Fornai, GU Corsini
Journal of neurochemistry 59 (2), 733-739, 1992
|Practitioner review: current best practice in the use of parent training and other behavioural interventions in the treatment of children and adolescents with attention deficit …|
D Daley, S Van der Oord, M Ferrin, S Cortese, M Danckaerts, M Doepfner, ...
Journal of Child Psychology and Psychiatry 59 (9), 932-947, 2018
|The control of responsiveness in ADHD by catecholamines: evidence for dopaminergic, noradrenergic and interactive roles|
RD Oades, AG Sadile, T Sagvolden, D Viggiano, A Zuddas, P Devoto, ...
Developmental Science 8 (2), 122-131, 2005
|Randomised controlled trials of selective serotonin reuptake inhibitors in treating depression in children and adolescents: a systematic review and meta-analysis|
T Usala, A Clavenna, A Zuddas, M Bonati
European neuropsychopharmacology 18 (1), 62-73, 2008
|Second generation antipsychotics (SGAs) for non-psychotic disorders in children and adolescents: a review of the randomized controlled studies|
A Zuddas, R Zanni, T Usala
European Neuropsychopharmacology 21 (8), 600-620, 2011